Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antimicrobial glycoconjugate vaccines: an overview of classic and modern approaches for protein modification
Francesco Berti, Roberto Adamo
Chemical Society Reviews (2018) Vol. 47, Iss. 24, pp. 9015-9025
Open Access | Times Cited: 96

Showing 26-50 of 96 citing articles:

Breakthrough of glycobiology in the 21st century
Gehendra Mahara, Cuihong Tian, Xiaojia Xu, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 10
Cell-Free Synthesis System: An Accessible Platform from Biosensing to Biomanufacturing
Yongbin Chen, Wenhao Xia, Fuping Lu, et al.
Microbiological Research (2025) Vol. 293, pp. 128079-128079
Closed Access
Synthesis of Aryl Thioglycosides by Metal-Free Arylation of Glycosyl Thiols with Diaryliodonium Salts under Basic Conditions
Anand Gaurav, Pintu Kumar Mandal
Carbohydrate Research (2025) Vol. 552, pp. 109437-109437
Closed Access
Residue-Specific Protein-Glycan Conjugation Strategies for the Development of Pharmaceutically Promising Glycoconjugate Vaccines: A Recent Update
Rajib Sarkar, A. Bandyopadhyay, Goutam Brahmachari
Carbohydrate Research (2025), pp. 109476-109476
Closed Access
Versatile Glycosyl Sulfonates in β‐Selective C‐Glycosylation
Jesse Ling, Clay S. Bennett
Angewandte Chemie International Edition (2019) Vol. 59, Iss. 11, pp. 4304-4308
Open Access | Times Cited: 28
Current Advances in Burkholderia Vaccines Development
Guanbo Wang, Paulina Zarodkiewicz, Miguel A. Valvano
Cells (2020) Vol. 9, Iss. 12, pp. 2671-2671
Open Access | Times Cited: 25
The Development of Vaccines from Synthetic Tumor‐Associated Mucin Glycopeptides and their Glycosylation‐Dependent Immune Response
Natascha Stergiou, Moritz Urschbach, Adele Gabba, et al.
The Chemical Record (2021) Vol. 21, Iss. 11, pp. 3313-3331
Open Access | Times Cited: 22
The biosynthetic origin of ribofuranose in bacterial polysaccharides
Steven D. Kelly, Danielle M. Williams, Jeremy T. Nothof, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 5, pp. 530-537
Closed Access | Times Cited: 16
Site-selective reactions for the synthesis of glycoconjugates in polysaccharide vaccine development
Lei Lin, Meng Qiao, Xing Zhang, et al.
Carbohydrate Polymers (2019) Vol. 230, pp. 115643-115643
Closed Access | Times Cited: 23
Application of an O-Linked Glycosylation System in Yersinia enterocolitica Serotype O:9 to Generate a New Candidate Vaccine against Brucella abortus
Jing Huang, Chao Pan, Peng Sun, et al.
Microorganisms (2020) Vol. 8, Iss. 3, pp. 436-436
Open Access | Times Cited: 21
Chemical (neo)glycosylation of biological drugs
Raoul Walther, Alexander N. Zelikin
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 62-76
Closed Access | Times Cited: 19
Retaining the structural integrity of disulfide bonds in diphtheria toxoid carrier protein is crucial for the effectiveness of glycoconjugate vaccine candidates
Filippo Carboni, Annabel Kitowski, Charlotte Sorieul, et al.
Chemical Science (2022) Vol. 13, Iss. 8, pp. 2440-2449
Open Access | Times Cited: 14
Glycan and Protein Analysis of Glycoengineered Bacterial E. coli Vaccines by MALDI-in-Source Decay FT-ICR Mass Spectrometry
Simone Nicolardi, Renzo Danuser, Viktoria Dotz, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 12, pp. 4979-4987
Open Access | Times Cited: 14
Carrier diversity and chemical ligations in the toolbox for designing tumor-associated carbohydrate antigens (TACAs) as synthetic vaccine candidates
René Roy, Leila Mousavifar
Chemical Society Reviews (2023) Vol. 52, Iss. 10, pp. 3353-3396
Closed Access | Times Cited: 7
A Glycotherapeutic Approach to Functionalize Biomaterials‐Based Systems
Anuja Gadekar, Sirsendu Bhowmick, Abhay Pandit
Advanced Functional Materials (2020) Vol. 30, Iss. 44
Open Access | Times Cited: 20
Shotgun scanning glycomutagenesis: A simple and efficient strategy for constructing and characterizing neoglycoproteins
Mingji Li, Xiaolu Zheng, Sudhanshu Shanker, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 39
Open Access | Times Cited: 16
Cross reacting material (CRM197) as a carrier protein for carbohydrate conjugate vaccines targeted at bacterial and fungal pathogens
Е. А. Хатунцева, Nikolay E. Nifantiev
International Journal of Biological Macromolecules (2022) Vol. 218, pp. 775-798
Closed Access | Times Cited: 12
Optimization of the Synthesis and Conjugation of the Methyl Rhamnan Tip of Pseudomonas aeruginosa A-Band Polysaccharide and Immunogenicity Evaluation for the Continued Development of a Potential Glycoconjugate Vaccine
Mohammad P. Jamshidi, Chantelle Cairns, Nam Huan Khieu, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 4, pp. 1361-1369
Open Access | Times Cited: 2
Modeling 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP) Chemistry to Design Glycoconjugate Vaccines with Desired Structural and Immunological Characteristics
Rebecca Nappini, Renzo Alfini, Salvatore Durante, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 707-707
Open Access | Times Cited: 2
Conjugation Methods in Synthetic Glycoconjugate Vaccines
Zirong Huang, Sheng Chen, Xuechen Li, et al.
Chemistry - Methods (2024) Vol. 4, Iss. 7-8
Open Access | Times Cited: 2
Glycoconjugate vaccines, production and characterization
Ralph Biemans, Francesca Micoli, Maria Rosaria Romano
Elsevier eBooks (2020), pp. 285-313
Closed Access | Times Cited: 17
Development and Immunogenicity of a Prototype Multivalent Group B Streptococcus Bioconjugate Vaccine
Jeremy A. Duke, Amy V. Paschall, Lloyd S. Robinson, et al.
ACS Infectious Diseases (2021) Vol. 7, Iss. 11, pp. 3111-3123
Open Access | Times Cited: 15
Classical- and bioconjugate vaccines: comparison of the structural properties and immunological response
Maria Rosaria Romano, Francesco Berti, Rino Rappuoli
Current Opinion in Immunology (2022) Vol. 78, pp. 102235-102235
Closed Access | Times Cited: 11
Site‐Specific Multi‐Functionalization of the Carrier Protein CRM197 by Disulfide Rebridging for Conjugate Vaccine Development
Nino Trattnig, Zeshi Li, Gerlof P. Bosman, et al.
ChemBioChem (2022) Vol. 23, Iss. 21
Open Access | Times Cited: 11
Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods
Víctor Morais, Norma Suárez
Bioengineering (2022) Vol. 9, Iss. 12, pp. 774-774
Open Access | Times Cited: 11

Scroll to top